HEMOLUNG 15.5 FR JUGULAR CATHETER TRAY KIT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-10-31 for HEMOLUNG 15.5 FR JUGULAR CATHETER TRAY KIT manufactured by Alung Technologies, Inc.

Event Text Entries

[125605607] Alung was notified of a serious deterioration in the state of health which resulted in a medical intervention. The research nurse and doctor were called in immediately from the next door room. After closer inspection they noticed the bleeding was coming from a crack in the ij catheter. Therapy was stopped and the lines clamped. Pressure was applied to the insertion site. The patient became tachycardia and hypotensive and the patient was treated with fluid, blood, and metaraminol. The decision was made to remove line, and direct pressure applied for 30 minutes as per protocol. No evidence of bleeding from insertion site, and there was a suture applied. The patient was monitored for further bleeding per protocol. After closer inspection they noticed the bleeding was coming from a crack in the ij catheter. There was a medical intervention that was required as a result of the blood loss and drop in blood pressure. The patient was given 2 units of blood and drugs to increase his blood pressure due to the loss of blood. On (b)(4) 2018, alung (b)(4) spoke to the research nurse, who confirmed the catheter serial number is (b)(4). The patient remains stable with no further issues related to the issue or sudden end of therapy. (b)(4) informed the research nurse that the explant kit is on its way and an engineer will be downloading the datalog and test the controller when the controller is available. Alung is taking the following actions: continue discussions with the physician and hospital staff to determine if there is any additional information relevant to the case. Alung will collect the controller data log and analyze the system performance during the case therapy. Complete explant analysis of the hemolung catheter. Alung will follow-up or close the case in 30 days. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[125605608] Alung was notified of a serious deterioration in the state of health which resulted in a medical intervention. After hospital staff rolled the patient they noticed a large amount of bleeding from the insertion site. The research nurse and doctor were called in immediately from the next door room. After closer inspection they noticed the bleeding was coming from a crack in the ij catheter. Therapy was stopped and the lines clamped. Pressure was applied to the insertion site. The patient became tachycardia and hypotensive and the patient was treated with fluid, blood, and metaraminol. The decision was made to remove lin, and direct pressure applied for 30 minutes as per protocol. No evidence of bleeding from insertion site, and there was a suture applied. The patient was monitored for further bleeding per protocol. The catheter has been retained for inspection by alung. The site couldn't remember if the hemolung was alarming due to the emergent situation. The patient is stable after receiving 2 units blood and drugs to increase blood pressure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3009763347-2018-00003
MDR Report Key8023347
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-10-31
Date of Report2018-10-26
Date of Event2018-10-19
Date Mfgr Received2018-10-19
Device Manufacturer Date2017-05-31
Date Added to Maude2018-10-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. FRANK FALCIONE
Manufacturer Street2500 JANE STREET SUITE 1
Manufacturer CityPITTSBURGH PA 15203
Manufacturer CountryUS
Manufacturer Postal15203
Manufacturer Phone4126973370
Manufacturer G1ALUNG TECHNOLOGIES, INC
Manufacturer Street2500 JANE STREET SUITE 1
Manufacturer CityPITTSBURGH PA 15203
Manufacturer CountryUS
Manufacturer Postal Code15203
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOLUNG 15.5 FR JUGULAR CATHETER TRAY KIT
Generic NameHEMOLUNG CATHETER
Product CodeDQR
Date Received2018-10-31
Returned To Mfg2018-12-14
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerALUNG TECHNOLOGIES, INC
Manufacturer Address2500 JANE STREET SUITE 1 PITTSBURGH PA 15203 US 15203


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-10-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.